Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0015695 (
fatty liver
)
13,941
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Leptin regulates energy balance and body weight by activating its receptor LEPRb and multiple downstream signaling pathways, including the STAT3 and the IRS2/PI 3-kinase pathways, in the hypothalamus. Leptin stimulates activation of LEPRb-associated JAK2, which initiates cell signaling. Here we identified
SH2-B
, a JAK2-interacting protein, as a key regulator of leptin sensitivity, energy balance, and body weight.
SH2-B
homozygous null mice were severely hyperphagic and obese and developed a metabolic syndrome characterized by hyperleptinemia, hyperinsulinemia, hyperlipidemia,
hepatic steatosis
, and hyperglycemia. The expression of hypothalamic orexigenic NPY and AgRP was increased in
SH2-B
(-/-) mice. Leptin-stimulated activation of hypothalamic JAK2 and phosphorylation of hypothalamic STAT3 and IRS2 were significantly impaired in
SH2-B
(-/-) mice. Moreover, overexpression of
SH2-B
counteracted PTP1B-mediated inhibition of leptin signaling in cultured cells. Our data suggest that
SH2-B
is an endogenous enhancer of leptin sensitivity and required for maintaining normal energy metabolism and body weight in mice.
...
PMID:Identification of SH2-B as a key regulator of leptin sensitivity, energy balance, and body weight in mice. 1609 27